时间 | 题目 | 讲者 |
---|---|---|
10:00-10:15 |
NR1 on PMN-MDSCs is a potential target for cancer immunotherapy |
罗敏 |
NSR on PMN-MDSCs is a potential target for cancer immunotherapy |
Min Luo | |
10:15-10:30 |
间充质干细胞为载体的实体瘤免疫疗法 |
马斌 |
Bin Ma | ||
10:30-10:40 |
Novel oncolytic adenovirus mediates vascular normalization and tertiary lymphoid structure formation by activating the STING pathway of DCs |
贺腾 |
Novel oncolytic adenovirus mediates vascular normalization and tertiary lymphoid structure formation by activating the STING pathway of DCs |
Teng He | |
10:40-10:50 |
射频消融联合TIGIT单抗的协同抗肿瘤作用 |
陈亚平 |
Yaping Chen | ||
10:50-11:00 |
Oncolytic activity of a chimeric influenza A virus carrying human CTLA4 antibody in hepatocellular carcinoma |
杨豪 |
Oncolytic activity of a chimeric influenza A virus carrying human CTLA4 antibody in hepatocellular carcinoma |
Hao Yang | |
11:00-11:10 |
Single-cell profiling of human CD127+ innate lymphoid cells reveals diverse immune phenotypes in the hepatocellular carcinoma microenvironment |
孔德源 |
Single-cell profiling of human CD127+ innate lymphoid cells reveals diverse immune phenotypes in the hepatocellular carcinoma microenvironment |
Deyuan Kong | |
11:10-11:20 |
PD-1+CXCR5-CD4+ Th-CXCL13 cell subset drives B cells into tertiary lymphoid structures of nasopharyngeal carcinoma |
李江平 |
PD-1+CXCR5-CD4+ Th-CXCL13 cell subset drives B cells into tertiary lymphoid structures of nasopharyngeal carcinoma |
Jiangping Li |